Cartesian Therapeutics
RNAC
#6732
Rank
โ‚น39.78 B
Marketcap
โ‚น1,665
Share price
3.61%
Change (1 day)
-39.33%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -โ‚น26.30

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น26.91. In 2021 the company made an earnings per share (EPS) of -โ‚น20.18 an increase over its 2020 EPS that were of -โ‚น58.02.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น26.30
2021-โ‚น20.18-65.22%
2020-โ‚น58.02-43.44%
2019-โ‚น102.59-58.08%
2018-โ‚น244.70-9.35%
2017-โ‚น269.93-29.16%
2016-โ‚น381.04